Expansion opportunities Rapid geographic growth with new Ireland clinic and Harley Street expansion signals ongoing demand for memory and cognitive care services; potential sales use cases include expanding collaboration with pharma partners, clinical trial recruitment support, and enterprise referrals across the UK, Ireland, and US.

Alzheimer's treatment adoption Launch of Kisunla (donanemab) and access to Leqembi and other disease-modifying therapies position Re:Cognition Health as a partner for early access programs, payer discussions, and patient recruitment for trials targeting early-stage Alzheimer's.

Private care leadership Specialized private mental health and memory clinics across multiple regions create opportunities to offer ancillary services, technology platforms, or support tools to improve diagnostics, trial screening efficiency, and patient experience for corporate and insurance partnerships.

Tech-enabled growth Adopted tech stack (Google Ads, iCIMS, OneTrust, WordPress, Mailchimp, analytics tools) suggests readiness for marketing automation, candidate sourcing, compliance workflows, and patient recruitment campaigns to scale outreach and trial enrollment.

Recognition and leadership Leadership visibility, including a female founder being featured and international clinic openings, creates credibility for co-development deals, sponsorships, and strategic partnerships with pharma, research organizations, and health systems seeking reputable memory care and clinical trial recruitment partners.